ECMM Candida Registry - CandiReg

The specific objectives are:

To describe the global incidence of invasive Candida infection To monitor trends globally and locally over time To define patient risk groups To assess antifungal resistance among Candida spp. causing invasive diseases worldwide To assess attributable mortality of invasive Candida infection To assess incremental costs associated with invasive Candida infection

To describe the clinical pattern of disease To document diagnostic procedures performed for confirmation of diagnosis To describe first-line and salvage treatment regimens applied, guideline adherence, their efficacy and impact on patient survival To inform consensus guidelines To develop clinical screening and diagnostic procedures

Set up of a collection of isolates with molecular characterization and evaluation of resistance genes

Inclusion criteria

• Cultural, histopathological, antigen or DNA evidence of invasive fungal infection with Candida species.
• Hepatosplenic candidiasis with signs of disseminated Candida infection without culture, histological or microscopic evidence
• Case control

Matching procedure for controls:

In part, controls will be included at the same hospitals that include cases (i.e. each one control per case, both in the same hospital).

Controls will be matched by demographics, underlying diseases and risk factors as well as duration of hospitalization

Exclusion criteria

• Colonization or other non-invasive infection, including superficial skin infections, candiduria without dissemination or Candida spp. in stool.